Maynard Um
-
-
-
-
-
-
-
CNS Pharmaceuticals names Lynne Kelley as chief medical officer
-
-
-
-
-
-
-
CNS Pharmaceuticals Announces CEO Transition
-
-
-
-
-
-
-
CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
-
-
-
-
-
-
-
CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
-
-
-
-
-
-
-
CNS Pharmaceuticals Announces Reverse Stock Split
-
-
-
-
-
-
-
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
-
396,364 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

